Pfenex’ Forteo biosimilar PF708 secures FDA approval for osteoporosis

Image: Pfenex bags FDA approval for PF708 for the treatment of osteoporosis. Photo: courtesy of The U.S. Food and Drug Administration/Wikipedia.org.